Weekly Research Analysts’ Ratings Updates for Sotera Health (SHC)

A number of firms have modified their ratings and price targets on shares of Sotera Health (NASDAQ: SHC) recently:

• 8/7/2026 – Sotera Health had its price target raised by Citigroup Inc. from $23.00 to $25.00. They now have a “buy” rating on the stock.
• 8/7/2026 – Sotera Health had its price target raised by Barclays PLC from $19.00 to $22.00. They now have an “overweight” rating on the stock.
• 8/7/2026 – Sotera Health had its “overweight” rating reaffirmed by Piper Sandler. They now have a $25.00 price target on the stock, up from $22.00.
• 8/7/2026 – Sotera Health had its price target raised by JPMorgan Chase & Co. from $16.00 to $18.00. They now have a “neutral” rating on the stock.
• 7/9/2026 – Sotera Health was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
• 6/24/2026 – Sotera Health was given a new $19.00 price target by UBS Group AG.
• 6/24/2026 – Sotera Health had its price target raised by Barclays PLC from $18.00 to $19.00. They now have an “overweight” rating on the stock.

Insider Transactions at Sotera Health

In other Sotera Health news, insider Michael P. Rutz sold 150,000 shares of Sotera Health stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $18.84, for a total transaction of $2,826,000.00. Following the transaction, the insider directly owned 334,279 shares of the company’s stock, valued at $6,297,816.36. The trade was a 30.97% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 15.36% of the company’s stock.

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.